Clinical Trials Logo
  1. Home
  2. Endometriosis
  3. NCT04840329
  4. Details
NCT04840329 Clinical Trial

Endocation: Trial of an Endometriosis Education Program

Endometriosis Clinical Trial

Official title:
Endocation: A Randomized Cluster Controlled Trial of an Endometriosis Education Program for Middle and Secondary School Students

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04840329
Other study ID # H19-00978
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 9, 2021
Est. completion date May 20, 2021

Study information
Verified date February 2023
Source BC Women's Hospital & Health Centre
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Endometriosis is a common condition that affects 10% of females, causing chronic pain and other health concerns. Currently, it takes 8-12 years to be diagnosed with endometriosis, in part because there is low awareness of this condition. This research is designed to test whether providing endometriosis education in schools can help increase early awareness of the condition.

Recruitment information / eligibility
Status Completed
Enrollment 67
Est. completion date May 20, 2021
Est. primary completion date May 20, 2021
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - 8-12 grade level class Exclusion Criteria: - Instruction offered in a language other than English

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• Education
One-time educational session about menstrual health and endometriosis

Locations
Country Name City State
Canada BC Women's Hospital Vancouver British Columbia

Sponsors (2)
Lead Sponsor Collaborator
BC Women's Hospital & Health Centre BC Support Unit

Country where clinical trial is conducted

Canada, 

Outcome
Type Measure Description Time frame Safety issue
Primary Change from baseline in menstrual health and endometriosis knowledge Assessed using a built for purpose questionnaire, possible scores range from 0 to 8 Baseline and 4 weeks
Secondary Change from baseline in prioritization of menstrual health Assessed using a built for purpose item, possible scores range from 0 to 4 Baseline and 4 weeks
Secondary Change from baseline in confidence in endometriosis knowledge Assessed using a built for purpose item, possible scores range from 0 to 4 Baseline and 4 weeks
Secondary Change from baseline in comfort with menstrual health Assessed using a built for purpose item, possible scores range from 0 to 4 Baseline and 4 weeks
Secondary Acceptability of menstrual health and endometriosis education (quantitative) Assessed using a built for purpose questionnaire, possible scores range from 0 to 35 Immediately following education in intervention and waitlist control group
Secondary Acceptability of menstrual health and endometriosis education (qualitative) Assessed using open-ended responses a built for purpose questionnaire Immediately following education in intervention and waitlist control group
Secondary Refusal of participants invited to participate Number of participants who refuse to participate divided by the number of participants invited to participate Baseline
Secondary Retention of participants Number of participants completing the study divided by the number of participants enrolled 4 weeks
See also
  Status Clinical Trial Phase
Completed NCT01931670 - A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain Phase 3
Recruiting NCT05648669 - A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain Phase 3
Completed NCT04081532 - The Effectiveness of Laparoscopic Treatment of Superficial Endometriosis for Managing Chronic Pelvic Pain N/A
Recruiting NCT06101303 - Endometriosis Pain
Completed NCT04665414 - Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI
Completed NCT03690765 - Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone for Treatment of Confirmed Endometriosis
Recruiting NCT05153512 - ADOlescent DysmenoRrhea Endometriosis Assessment Magnetic Resonance Imaging (Adodream)
Active, not recruiting NCT04171297 - Ultrasound Evaluation of the Pelvis in Women With Suspected Endometriosis Scheduled for Laparoscopic Surgery
Recruiting NCT04172272 - The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures N/A
Completed NCT04565470 - Strategies of Self-management of Endometriosis Symptoms
Completed NCT03613298 - Treatment by HIFU With Focal One® of Posterior Deep Infiltrating Endometriosis Lesions With Intestinal Involvement. N/A
Withdrawn NCT05568940 - Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids
Not yet recruiting NCT03464799 - Does Immunotherapy Have a Role in the Management of Endometriosis?
Active, not recruiting NCT03002870 - Characteristics of Patient Population With Endometriosis N/A
Completed NCT02973854 - Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Endometriosis: Identification of Potential Relevant Biomarkers to Diagnose and Treat
Withdrawn NCT03272360 - Endometriosis Biomarker Discovery Study N/A
Recruiting NCT02481739 - Laparoscopic Surgical Management of Endometriosis on Fertility N/A
Active, not recruiting NCT02754648 - Three Different Laparoscopic Approaches for Ovarian Endometrioma and the Effect on Ovarian Reserve N/A
Completed NCT06106932 - GnRH-a on Angiogenesis of Endometriosis N/A
Completed NCT02387931 - Supplementation in Adolescent Girls With Endometriosis Phase 4